Forte Biosciences, Inc. — Director's Dealing 2019

Apr 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2019-04-15

Reporting Person: Kabbinavar Fairooz (SVP Clinical Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-15	Employee Stock Option (right to buy)	$9.94	A	100000	Acquired	2029-04-14	Common Stock (100000)	Direct

Footnotes

F1: 1/4th of the shares vest one year after 4/15/2019; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/15/2019.